The financial world is buzzing about the SEC's recent decision to block some new leveraged ETFs, especially those focused on tech and crypto. This move highlights the growing concern around complex investment products. Leveraged ETFs, which magnify gains and losses, are like powerful tools—useful in
The SEC has shaken things up in the crypto world. They've asked companies to pull their old ETF filings. Why? Because they've got a new rule. Now, crypto ETFs can be approved anytime, as long as they meet the right standards. This isn't a step back. It's a faster path to getting these ETFs out there
The crypto world is buzzing with news that Coinbase is pushing for a big change. They want to offer something called "tokenized equities" to their customers. This means turning regular stocks into digital tokens, like cryptocurrencies. Instead of owning actual shares, investors would own tokens that
In the 2024 election, cryptocurrency companies like Ripple spent millions in political contributions. This surge in spending has raised questions about the industry's influence in Washington. Brad Garlinghouse, CEO of Ripple, revealed that his company alone contributed $25 million to an industry sup
In the 2024 elections, the crypto industry made a calculated gamble. They spent big, targeting candidates who supported their cause and aiming to oust those who didn't. Among these targets was Ohio Senator Sherrod Brown, who was defeated by political newcomer Bernie Moreno. Moreno, a former car sale
The exchange-traded funds (ETF) sector is preparing for big changes starting in 2025, and who wins Tuesday's election might influence these changes. A likely victory for Republican Donald Trump could mean less strict rules than the past four years. Whoever comes into office, ETF companies are gettin
The Trump family has been making waves in the crypto world with their new project, World Liberty Financial. The team behind the endeavor, which includes Donald Trump Jr., Eric Trump, and Barron Trump, has been teasing the public with vague descriptions, promising that it will be a game-changer. But
